中毒患者体外膜氧合应用病例报告现状评估及进一步改进建议
该研究检索MEDLINE和PubMed数据库中英文全文发表的关于中毒患者使用ECMO的病例报告,排除缺乏个体ECMO数据、考虑但未使用ECMO或未明确毒物的文献。共纳入150例病例,分析其对体外生命支持组织马斯特里赫特命名建议各层级、设备设置、毒物实验室记录及临床疗效证据的报告情况。结果显示仅1%记录了全部四个层级,仅28%提供了插管位置和尺寸细节,设备设置、毒物实验室记录和临床疗效证据的报告率均低,且与期刊类型无关。作者认为,毒理学家、ECMO重症医师和外科医生在报告病例时应提供足够细节,以便其他专科医生判断ECMO对特定中毒是否有效,并提出一系列建议以改进未来发表。
要点
- 150例中毒患者ECMO病例报告中,仅1%记录了体外生命支持组织马斯特里赫特命名建议的全部四个层级。
- 仅28%的病例报告同时提供了插管位置和尺寸细节,设备设置和毒物实验室记录的报告率也低。
- 临床疗效证据的报告率低,且与期刊类型无关。
- 作者建议未来发表应重点描述物理设置、设备参数和相关的临床疗效证据,作为必要组成部分。
适用人群与场景
- 中毒患者使用体外膜氧合(ECMO)的病例报告,纳入英文全文发表且有个体ECMO数据的病例;排除考虑但未使用ECMO、缺乏个体ECMO数据或未明确毒物的文献。
研究设计与关键结果
- 研究类型为病例报告文献评估,共纳入150例病例,检索MEDLINE和PubMed数据库。
- 仅1%的病例记录了体外生命支持组织马斯特里赫特命名建议的全部四个层级。
- 仅28%的病例提供了插管位置和尺寸细节。
- 设备设置、毒物实验室记录和临床疗效证据的报告率均低,且与期刊类型无关。
证据类型、等级与局限
- 证据类型为病例报告的系统性评估,原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,毒理学家、ECMO重症医师和外科医生在报告病例时应提供足够细节,以便其他专科医生判断ECMO对特定中毒是否有效。
- 作者建议未来发表应重点描述物理设置、设备参数和相关的临床疗效证据,作为必要组成部分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Extracorporeal membrane oxygenation is an important therapeutic option for the critically ill poisoned patient, but data are limited mainly to case reports and case series. A lack of thorough reporting of specific extracorporeal membrane oxygenation details or the resultant physiological response may lead to misinterpretation of the effectiveness of extracorporeal membrane oxygenation, limiting its generalizability.
METHODS: We searched MEDLINE and PubMed databases using the criteria "extracorporeal membrane oxygenation" or "ECMO" AND "poisoning" or "overdose" and limited the selection to English language publications for which full text was available. Publications were excluded if they lacked data on extracorporeal membrane oxygenation for individual cases, extracorporeal membrane oxygenation was considered but not used, or a poison(s) was not identified. Each case was analyzed separately for reporting of each component (level) of the Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support recommendations, a composite outcome if multiple levels were reported, device settings, laboratory documentation of poison(s), and outcomes by journal type. A subgroup analysis evaluated the reporting of clinical evidence of therapeutic effect.
RESULTS: Of 150 cases included, only 1% had documentation of all four levels, and only 28% provided both cannula location and dimension details. Documentation of device settings, laboratory documentation of poison(s), and clinical evidence of therapeutic effect were also low, regardless of journal type.
DISCUSSION: It is critical for toxicologists, extracorporeal membrane oxygenation intensivists and surgeons to provide sufficient details when they report their cases so that other specialists, particularly those deciding whether to use this intervention, may determine if extracorporeal membrane oxygenation was effective for the specific poisonings reported.
CONCLUSIONS: Few publications provide sufficient documentation to fully assess the clinical role of extracorporeal membrane oxygenation in poisoned patients. We propose a series of recommendations to improve future publications, emphasizing that descriptions of the physical setup, device parameters, and pertinent clinical evidence of therapeutic effect should be essential components.
参考来源
- Horowitz KM, Ran R, Hendrickson RG, et al. An evaluation of the current case reporting of extracorporeal membrane oxygenation use in poisoned patients and recommendations for further improvement. Clin Toxicol (Phila). 2025. PMID: 41170729. doi:10.1080/15563650.2025.2573043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。